Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma

Esophageal squamous cell carcinoma (ESCC) is a common gastrointestinal cancer and is often refractory to current therapies. Development of efficient therapeutic strategies against ESCC presents a major challenge. Glycogen synthase kinase (GSK)3β has emerged as a multipotent therapeutic target in var...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolidong, Dilireba, Domoto, Takahiro, Uehara, Masahiro, Sabit, Hemragul, Okumura, Tomoyuki, Endo, Yoshio, Nakada, Mitsutoshi, Ninomiya, Itasu, Miyashita, Tomoharu, Wong, Richard W., Minamoto, Toshinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367341/
https://www.ncbi.nlm.nih.gov/pubmed/32678196
http://dx.doi.org/10.1038/s41598-020-68713-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367341/
https://www.ncbi.nlm.nih.gov/pubmed/32678196
http://dx.doi.org/10.1038/s41598-020-68713-9

Ejemplares similares